FIELD OF THE INVENTION
The invention relates generally to the field of formulation chemistry. More particularly, the invention relates to compounds, compositions, and methods for specifically inhibiting poly(ADP)-ribose polymerase 1 (PARP1) and for treating PARP1-associated diseases including, for
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims priority of PCT/CN2011/074519 filed May 23, 2011 under 35 U.S.C. .sctn.371(c).
FIELD
The present application is directed to organic chemistry and pharmaceutical chemistry.
BACKGROUND
Poly(ADP-ribose)polymerase, PARP, is also known as